Cargando…
Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643486/ https://www.ncbi.nlm.nih.gov/pubmed/37957175 http://dx.doi.org/10.1038/s41408-023-00941-4 |
| _version_ | 1785147123648430080 |
|---|---|
| author | Xu, Dan Yang, Ying Yin, Zhao Tu, Sanfang Nie, Danian Li, Yiqing Huang, Zhenqian Sun, Qixin Huang, Changfen Nie, Xiaqi Yao, Zurong Shi, Pengcheng Zhang, Yu Jiang, Xuejie Liu, Qifa Yu, Guopan |
| author_facet | Xu, Dan Yang, Ying Yin, Zhao Tu, Sanfang Nie, Danian Li, Yiqing Huang, Zhenqian Sun, Qixin Huang, Changfen Nie, Xiaqi Yao, Zurong Shi, Pengcheng Zhang, Yu Jiang, Xuejie Liu, Qifa Yu, Guopan |
| author_sort | Xu, Dan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10643486 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106434862023-11-13 Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study Xu, Dan Yang, Ying Yin, Zhao Tu, Sanfang Nie, Danian Li, Yiqing Huang, Zhenqian Sun, Qixin Huang, Changfen Nie, Xiaqi Yao, Zurong Shi, Pengcheng Zhang, Yu Jiang, Xuejie Liu, Qifa Yu, Guopan Blood Cancer J Correspondence Nature Publishing Group UK 2023-11-13 /pmc/articles/PMC10643486/ /pubmed/37957175 http://dx.doi.org/10.1038/s41408-023-00941-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Xu, Dan Yang, Ying Yin, Zhao Tu, Sanfang Nie, Danian Li, Yiqing Huang, Zhenqian Sun, Qixin Huang, Changfen Nie, Xiaqi Yao, Zurong Shi, Pengcheng Zhang, Yu Jiang, Xuejie Liu, Qifa Yu, Guopan Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study |
| title | Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study |
| title_full | Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study |
| title_fullStr | Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study |
| title_full_unstemmed | Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study |
| title_short | Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study |
| title_sort | risk-directed therapy based on genetics and mrd improves the outcomes of aml1-eto-positive aml patients, a multi-center prospective cohort study |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643486/ https://www.ncbi.nlm.nih.gov/pubmed/37957175 http://dx.doi.org/10.1038/s41408-023-00941-4 |
| work_keys_str_mv | AT xudan riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT yangying riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT yinzhao riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT tusanfang riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT niedanian riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT liyiqing riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT huangzhenqian riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT sunqixin riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT huangchangfen riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT niexiaqi riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT yaozurong riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT shipengcheng riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT zhangyu riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT jiangxuejie riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT liuqifa riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy AT yuguopan riskdirectedtherapybasedongeneticsandmrdimprovestheoutcomesofaml1etopositiveamlpatientsamulticenterprospectivecohortstudy |